Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2009 Results
Date:4/29/2009

Circadian Rhythm Sleep Disorders.

FINANCIAL DETAILS

* Operating Expenses. First quarter 2009 R&D expenses of $2.3 million,

consisted primarily of $0.5 million of salaries and benefits and

$0.2 million of non-cash stock based compensation costs for R&D

personnel, as well as $0.8 million of regulatory consultant fees,

and $0.2 million of pre-clinical work. This compares to

$3.6 million for the fourth quarter of 2008 and $11.1 million for

the first quarter of 2008. The decrease in R&D expenses in the first

quarter of 2009 relative to the fourth quarter of 2008 is primarily

due to the decrease in regulatory consulting and other professional

fees related to iloperidone. The decrease in R&D expenses in the

first quarter of 2009 relative to the first quarter of 2008 is

primarily due to the completion in the second quarter of 2008 of the

Phase III clinical trial for tasimelteon in chronic primary

insomnia.

General and administrative (G&A) expenses of $4.2 million for the

first quarter of 2009 consisted primarily of $0.5 million of

salaries and benefits and $2.1 million of non-cash stock based

compensation costs for G&A personnel, as well as $0.7 million of

legal fees, and $0.2 million of insurance costs. This compares to

$4.1 million for the fourth quarter of 2008 and $9.0 million for the

first quarter of 2008. The increase in G&A expenses in the first

quarter of 2009 relative to the fourth quarter of 2008 is primarily

due to an increase in legal and professional fees offset by a

decrease in stock-based compensation costs. The decrease in
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
2. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
3. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
6. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
7. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
8. Onyx Pharmaceuticals Announces First Quarter 2009 Financial Results Teleconference and Webcast
9. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
10. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
11. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Bill Jacobs Automotive, a group of car dealerships headquartered in ... Heartland Blood Center and offering free oil change coupons for ... Saturday, Jan. 18 at the Bill Jacobs Cadillac and Chevrolet ... http://photos.prnewswire.com/prnh/20140115/MN46637 )  The Bill Jacobs Auto ...
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... to win races on the Formula 1 track could help ... between McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based ... funded by healthcare provider Simplyhealth. Telemetry technology, which ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 DTS ... to its Online Web Portal for Life Science organizations who ... to specify the subject matter of their documents in advance ... will help reduce time-to-delivery of translations, often a critical factor ...
Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2
... 1 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) is pleased ... on May 8, 2008 at 9:00 pm MDT ... and the business aspects of the Company. Following ... answer session., The webcast can be accessed ...
... - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... today announced that it has received 510(k),clearance from ... begin,marketing sizes 3-0 and 4-0 of its Quill ... SRS PDO is a longer-lasting,absorbable suture, which is ...
... SOUTH SAN FRANCISCO, Calif., May 1 Renovis,Inc. (Nasdaq: ... the,adoption of the merger agreement with Evotec AG (Frankfurt ... today. The merger is,expected to close by May 5, ... share of Renovis common,stock will be automatically converted into ...
Cached Biology Technology:Resverlogix Notice of Conference Call & Webcast 2Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 2Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 3Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO 4Renovis Stockholders Approve Acquisition by Evotec 2
(Date:4/23/2014)... greater prevalence of asthma, allergies and other chronic inflammatory ... due in part to their reduced exposure to the ... new scientific paper. , The article, published in the ... people living in urban centers who have less access ... chronic inflammation, a condition caused by immune system dysfunction. ...
(Date:4/23/2014)... with Huntington,s disease, most in their mid-thirties and ... and behavioral decline within two decades. "Mutant" protein ... genetic disease, have been the primary focus of ... to new research from Prof. Gerardo Lederkremer and ... of Cell Research and Immunology, in collaboration with ...
(Date:4/23/2014)... 23, 2014) People who have had a stroke, ... neurological function. However, a study conducted in Taiwan, that ... Cell Transplantation , but is currently freely available on-line ... has found that when one group of stroke victims ... directly into the brain and a similar group did ...
Breaking Biology News(10 mins):Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... University of Leicester and part-funded by The Leverhulme Trust aims ... By bringing together an artist and a neuroscientist, both ... perception. In the process of the research, both artist and ... the eye of the beholder. Rodrigo Quian Quiroga, Neuroscientist ...
... opinion that inflammation in adipose tissue may cause insulin resistance, ... Swedish medical university Karolinska Institutet, published in the New ... in the body fat is only pernicious. Instead the findings ... necessary for fat cell turnover in the lean, healthy state. ...
... not just thinking big but also very, very, very ... director of Binghamton University,s Center for Advanced Sensors and ... that would detect and identify engineered nanoparticles. Her research ... the environmental release and transformation of these particles. ...
Cached Biology News:Beauty is in the eye of the beholder? 2Inflammation in body fat is not only pernicious 2Chemist monitors nanotechnology's environmental impact 2
A univariate (peak height or area) quantitative multi-component analysis package....
... The micro 1 is a dramatic breakthrough ... from 1mL with 10nL resolution, the micro 1 ... benchtop dispenser. And, the micro 1 never needs ... , Touch Screen programming on an LCD Display ...
... microscopes offer all of the features of ... Equipped with Koehler illumination, a centerable condenser ... B3 is the workhorse of Motic's range ... the need for re-focusing following a change ...
... Dye Primer Manual Cycle Sequencing Kit is ... primers and high-resolution fluorescence scanners. Sequencing reactions ... slab gel electrophoresis and scanning of the ... The kit components have been optimized ...
Biology Products: